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Abstract
Purpose—Reductions in risk behaviors are common following enrollment in HIV prevention 
studies. We develop methods to quantify the proportion of change in risk behaviors that can be 
attributed to regression to the mean versus study participation and other factors.
Methods—A novel model that incorporates both regression to the mean and study participation 
effects is developed for binary measures. The model is used to estimate the proportion of change 
© 2015 Published by Elsevier Inc.
Contact Information for Corresponding Author: James P. Hughes, PhD, Department of Biostatistics, University of Washington 
357232, Seattle, WA 98195, T: 206-616-2721, F: 206-616-2724, jphughes@uw.edu. 
Disclaimer: The views expressed herein are solely the responsibility of the authors and do not necessarily represent the official views 
of the National Institute of Allergy and Infectious Diseases, the National Institute of Mental Health, the National Institutes of Health, 
the HPTN, or its funders.
Trial Registration: Clinicaltrials.gov, NCT00995176, http://clinicaltrials.gov.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Ann Epidemiol. Author manuscript; available in PMC 2016 June 01.
Published in final edited form as:













in the prevalence of “unprotected sex in the past 6 months” that can be attributed to study 
participation versus regression to the mean in a longitudinal cohort of women at risk for HIV 
infection who were recruited from ten US communities with high rates of HIV and poverty. HIV 
risk behaviors were evaluated using audio computer-assisted self-interviews at baseline and every 
6 months for up to 12 months.
Results—The prevalence of “unprotected sex in the past 6 months” declined from 96% at 
baseline to 77% at 12 months. However, this change could be almost completely explained by 
regression to the mean.
Conclusions—Analyses that examine changes over time in cohorts selected for high or low risk 
behaviors should account for regression to the mean effects.
Keywords
HIV; Risk Behavior; Statistical model; Logistic Regression
Introduction
In HIV and STI prevention trials reported risk behaviors are often observed to decline over 
the course of the study, even in the control group1,2. Such declines may be attributed to a 
number of factors, including counseling messages and services provided by the study, a 
general increase in feelings of self-worth due to study participation, healthy survivor effects, 
aging of the participants, and/or the Hawthorne effect3. However, an important alternative 
explanation that should be considered, and can be quantified, is the phenomenon of 
regression to the mean4.
Regression to the mean (RTM) is a statistical phenomenon that occurs when study 
participants are selected for extreme values of characteristics or behaviors that vary over 
time. RTM predicts that subsequent measures of those characteristics or behaviors will, on 
average, be closer to the underlying population mean than the original values. For example, 
if subjects are selected such that 100% of participants have a particular behavior at 
enrollment, then (assuming the behavior varies over time) RTM predicts that the prevalence 
of that behavior will decline as the study progresses, even in the absence of any intervention. 
However, it is not clear how much of a decline might be expected due to RTM, and how 
rapidly the decline might occur.
RTM has been studied extensively, usually in the context of continuous measures (e.g. blood 
pressure5, heights of fathers and sons6, and medical costs7) or count data (sex acts, sex 
partners8). However, little has been written about RTM in the context of binary measures 
(e.g. unprotected sex in the past 6 months) even though such measures are common in 
epidemiologic and behavioral studies. In this manuscript we develop methods for estimating 
the expected change in the prevalence of a selected binary behavior due to RTM. We apply 
these methods to data from the HIV Prevention Trials Network Women's HIV 
SeroIncidence Study HPTN 0649 to quantify the amount of change in a key risk behavior – 
unprotected sex in the past 6 months – that is associated with study participation versus 
RTM.
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HPTN 064 was a multi-site, longitudinal cohort study designed to estimate HIV incidence 
among women at elevated risk for HIV infection. Details regarding the study design have 
been previously described9. In brief, eligible women were enrolled between May 2009 and 
July 2010 from 10 urban and periurban communities in six geographic areas of the US 
(Atlanta, GA; Baltimore, MD; New York City, NY; Newark, NJ; Raleigh-Durham, NC; 
Washington, DC) using venue-based recruitment. Specifically, women were recruited during 
randomly selected venue-time intervals within each community. Women entering the venue 
during the recruitment interval were sequentially or systematically (e.g. every 4th woman) 
approached for screening. Women who met inclusion criteria (see below) and agreed to 
enroll were followed at 6 month intervals for either 6 or 12 months, depending on date of 
enrollment. All participants completed HIV rapid testing and audio computer-assisted self-
interviews (ACASI) at baseline and each follow-up visit. The ACASI included questions 
regarding sexual behavior as well as socioeconomic factors, food insecurity, mental health, 
history of sexually transmitted infections (STIs), domestic violence, health perceptions, 
substance use, and social support.
Inclusion Criteria and Definitions
Eligible individuals were 18 to 44 years of age, self-identified as a woman (inclusive of 
transgender women) and reported, during a face-to-face screening interview, at least one 
episode of unprotected vaginal and/or anal sex with a man in the 6 months before enrollment 
(based on the screening question “When did you last have unprotected sex with a man?”, 
where sex was defined as vaginal or anal sex). Two additional inclusion criteria were that 
individuals:
1. Reported one or more of the following in the past 6 months, except for 
incarceration which could have occurred within the past 5 years: a) illicit injection 
and/or non-injection drug use (e.g. heroin, cocaine, crack cocaine, 
methamphetamine, and/or use of prescription drugs apart from those prescribed by 
a licensed provider), b) alcohol dependence (defined as CAGE Score ≥2)10, c) 
binge drinking, defined as consuming ≥4 drinks at one time, d) incarceration (jail 
and/or prison ≥24 hours), e) self-reported history of sexually transmitted infections 
(STIs): gonorrhea, chlamydia, or syphilis, f) exchange of sex for commodities (e.g., 
drugs, money, shelter), g) a male sexual partner with reported history of any of the 
following: injection or non-injection drug use, STIs, HIV diagnosis, history of 
binge drinking (consuming ≥5 drinks at one time), alcohol dependence, (CAGE 
Score ≥2), or incarceration (jail and/or prison ≥24 hours within past 5 years).
2. Reside in census tracts (except Bronx and Harlem where zip codes were used) that 
ranked in the top 30th percentile of HIV prevalence and where >25% of inhabitants 
lived below the US federal poverty threshold, as defined by the 2008 United States 
Census Bureau11,12.
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Exclusion criteria included self-reported history of a previous positive HIV test, current HIV 
prevention trial enrollment, current/past participation in an HIV vaccine trial, or anticipated 
absence for >2 consecutive months during the follow-up period.
Outcomes
The outcome of this analysis is unprotected vaginal or anal sex with any of the three most 
recent male partners during the past 6 months. This measure is based on the woman's 
ACASI report of her behavior with each of her three most recent partners and was 
consistently collected at baseline and each follow-up visit. Responses to the question “About 
how many times did you and this partner have vaginal (anal) sex without using a condom in 
the last 6 months?” for up to three partners were combined to create a measure that was 
coded as 1 if the woman reported unprotected sex with any partner, 0 if she reported no 
partners or only protected sex with all partners, and missing if she did not complete the 
follow-up visit or (rarely) if she indicated sex with partners but did not indicate whether a 
condom was used.
Due to the inclusion criteria, we expected that all enrolled women would respond “yes” to 
the unprotected sex questions on the ACASI at baseline. However, as noted above, a woman 
was eligible for participation if she indicated during screening that she had had unprotected 
sex with any man during the past 6 months, whereas the ACASI asked about the three most 
recent partners only. Thus, there are occasional discrepancies between the screening 
responses and the baseline ACASI responses. We detail these inconsistencies in the Results 
section.
Statistical Methods
Women who screened for the HPTN 064 study and met all the study eligibility criteria, 
except they may not have had unprotected sex in the past 6 months, will be referred to as the 
“unselected” population. We have data on the unprotected sex outcome at the screening 
and/or baseline visit on all participants in the unselected population (subject to the 
discrepancies mentioned above, screening and baseline results are equivalent for enrolled 
women). We have data at 6 and 12 months (depending on retention) only on participants 
who met all eligibility criteria, including the unprotected sex criterion, and enrolled. This 
subset of participants represents the “selected” population.
Define Xi =1 if a participant reports unprotected sex (with a man, in the past 6 months) at 
visit i (i = 0, 1, 2 corresponding to the baseline, 6 month and 12 month visits, respectively) 
and 0 otherwise. The following logistic regression model is used to capture the association 
between repeated measurements of X over time and the possibility that participation in a 
research study may affect X,
(1)
where Ei is 1 if the participant was participating in the study during the preceding 6 months 
(the period during which Xi was measured), and 0 otherwise. In the present analysis, Ei is 0 
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only at the baseline visit (i = 0). Standard maximum likelihood methods are used for 
parameter estimation for model (1) (see appendix).
In model (1), the log odds ratio of unprotected sex at the current visit increases by α1 if the 
participant reported unprotected sex at the previous visit, compared to if she did not report 
unprotected sex at the previous visit. α1 plays a role similar to correlation in studies of 
continuous measures. Small values of α1 (near 0) lead to rapid regression to the mean 
(typically characterized by a steep decline in behavior from enrollment to the first followup 
visit); large values imply that complete regression will take longer. Based on model (1) we 
may derive the probability of unprotected sex in the unselected population, which we denote 
as Pall (see appendix for derivation). In the absence of an intervention or study effect, Pall 
represents the prevalence that the selected population will regress towards following 
enrollment. For example, denote the baseline prevalence in the selected population by 
Pselected (e.g. if the behavior is required for eligibility then Pselected = 1). We expect to 
observe a change in prevalence from Pselected to Pall over time simply due to RTM.
The parameter α2 in model (1) quantifies the effect of study participation on the prevalence 
of the behavior. If α2 = 0, then there is no study effect while negative/positive values of α2 
imply that the prevalence of the behavior will decline/increase, beyond that predicted by 
regression to the mean, following study participation. The (long-term) on-study prevalence 
of the behavior may also be derived from model (1) and is denoted by Ponstudy (see appendix 
for derivation).
The difference between Pall and Ponstudy quantifies the “study effect” and the ratio
(2)
quantifies the proportion of the observed change in behavior from baseline that is associated 
with study participation. Negative values of (2) imply that the change in prevalence of the 
behavior over the course of the study is less than would be expected due to RTM. For 
instance, if we have selected for a high risk behavior, then a negative value for (2) implies 
that the prevalence of the behavior has not declined over the course of the study as much as 
predicted by RTM; effectively, the study is associated with an increase in the prevalence of 
the behavior.
Estimation in model (1) depends critically on having complete information on the 
prevalence of the behavior, X, in the unselected population. In the HPTN 064 study, this 
information was collected during screening for the key selection variable “unprotected sex 
with a male in the past 6 months” but was not available for other behaviors or characteristics 
(e.g. substance use, food insecurity, foregone medical care) that may be of interest.
Results
A total of 8029 women were screened for HPTN 064 (figure 1). Of those, 4126 women 
satisfied all eligibility criteria, aside from the requirement of unprotected sex in the last 6 
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months. Thus, these 4126 women represent (a sample from) the unselected population. At 
screening, a total of 3234 of these women (78.4%) reported unprotected sex with a male 
during the past 6 months (screened “positive”) and 2099 of these (64.9%) chose to 
participate in HPTN 064. Details on followup and retention are provided elsewhere9,13.
Table 1 shows the proportion of women reporting unprotected sex (with at least one of the 
three most recent partners) at each visit. Note that 91 of 2099 enrolled women (4.3%) 
indicated on the baseline ACASI that they had not had unprotected sex (with any of the last 
three male partners) in the past 6 months. To make the data on unenrolled women 
comparable to the data on the enrolled women, we assume that 4.3% (49) of the 1135 
eligible, screen positive women who chose not to enroll would also have responded “no” to 
the ACASI questions about unprotected sex, and we adjust the number of unenrolled women 
reporting unprotected sex from 1135 to 1086 (no information is available regarding what 
proportion of the 892 eligible women who reported no unprotected sex with a male during 
the past 6 months at screening might have answered “yes” to the unprotected sex questions 
if asked via ACASI, so these women are treated as if they would have responded “no” to the 
ACASI at baseline). After this adjustment, we estimate that 75% of women (3094/4126) in 
the unselected population would have responded “yes” at screening to the ACASI questions 
about any unprotected sex in the past 6 months with the last three partners.
The prevalence of unprotected sex in the past 6 months is observed to decline from 0.96 at 
baseline to 0.77 at 12 months (table 1). The adjusted data from table 1 was used to estimate 
the parameters of model (1). We estimate that the long-term on-study prevalence of 
unprotected sex is 0.74 (95% CI: 0.71 – 0.77) (table 2). Of this decline in unprotected sex 
during the study (from 0.96 to 0.74), only 4.4% (95% CI: -10%, 17%) cannot be explained 
by RTM and may be associated with study participation (see text following equation (2) for 
interpretation of a negative percentage). If no adjustments are made to the screening results 
(i.e. using N instead of Nadj from table 1), then 10% of the decline in unprotected sex during 
the study may be associated with study participation.
Discussion
When individuals are selected for high or low values of a time-varying quantity (e.g. 
presence of a risk behavior or biologic marker) and then measured again on that quantity, 
regression to the mean is inevitable. This phenomenon has been demonstrated in a wide 
variety of settings including education (e.g.. test scores14), medicine (e.g. treatment for 
hypertension5) and sports (e.g., the “sophomore slump”15), among others. Although less 
often discussed in the context of binary outcomes, the same principle applies – if a sample of 
individuals is selected to have a high or low prevalence of a time-varying behavior then, 
over time, the prevalence of that behavior will regress towards the prevalence in the 
unselected population.
In this manuscript we develop a model for RTM for binary measures that allows 
simultaneous estimation of the regression effect and study effect in the context of a 
prospective cohort selected for certain high risk behaviors. Applying these methods to 
HPTN 064, we found that most of the observed change over the course of the study in 
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unprotected sex in the last 6 months could be explained by RTM. Three key assumptions 
must be considered in interpreting this result. First, in HPTN 064 only a subset of the 
eligible women (65%) enrolled in the cohort. We assume that the women who enrolled in 
the study are representative of all the women who were eligible. Second, among women 
who enrolled, we assume there is no differential dropout with respect to the behavior of 
interest. Since retention in HPTN 064 was high (≥ 93%9) there is little potential for bias due 
to loss to followup (although the fact that, by design, only 77% of women were enrolled for 
12 months of followup decreases our sample size and increases the uncertainty of our 
estimates). Third, unlike the multivariate normal distribution for continuous data, there is no 
unique model for multivariate binary data. Thus, other models for the joint distribution of 
the Xi (eq. 1) could be proposed and these could lead to different estimates of the RTM 
effect. However, in one other model that we explored (a beta-binomial model), the results 
were qualitatively similar to those presented here (data not shown).
Importantly, estimation of the regression effect requires information on the prevalence of the 
behavior of interest in the unselected population. Obtaining these data could increase study 
costs (although it would be acceptable to collect data on a random subset of the unselected 
population). For this reason these data may not be systematically collected and, in any event, 
are typically not included in published data. Thus, it is difficult to quantitatively assess the 
RTM effect in other published studies that report declines in high risk behaviors during 
study participation. However, it is interesting to note that in the HVTN 906 study1, a study 
with similar design and unprotected sex eligibility requirements as HPTN 064, the 
prevalence of unprotected vaginal sex in the past 6 months declined from 99.6% at 
enrollment to 76.1% at 18 months, a result remarkably similar to that seen here. It is 
reasonable to hypothesize that a substantial portion of this decline may be due to RTM.
Model (1) assumes a constant study effect (quantified by α2) over the course of followup. 
Given the relatively brief followup in HPTN 064, a more complex model is not possible for 
these data. However, with a longer followup, model (1) could be extended to allow for a 
time-varying or transient study effect. Such an approach could be used to model e.g. a rapid 
initial decline in a high risk behavior followed by a partial return to a level representing the 
long term prevalence (strong initial study effect waning over time). Such a pattern was 
observed by Bartholow et al.16
In this manuscript, we have focused on change in the prevalence of a behavior that has been 
directly selected for based on study eligibility criteria. However, RTM may also explain 
changes in behaviors that are not subject to direct selection if those behaviors are highly 
correlated with the measures that form the eligibility criteria. For example, the behavior 
“condom use at last sex” is expected to be strongly (inversely) correlated with the selection 
variable “unprotected sex in the last 6 months”. Thus, direct selection on the latter measure 
may result in indirect selection on the former. As a consequence, we expect “condom use at 
last sex” to exhibit some RTM effect over the course of the study. If screening data on the 
prevalence of such indirectly selected measures are available, then the methods outlined 
above may be used to estimate the RTM effect. In the absence of such screening data (as is 
the case for “condom use at last sex” in HPTN 064) it may be possible to estimate the RTM 
effect in an indirectly selected measure based on the strength of its association with the 
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directly selected measure(s). For example, a sensitivity analysis presented in Hodder et al.9 
suggested that 30 – 60% of the observed increase in “condom use at last sex” could be 
attributed to RTM (stated differently, 40 – 70% associated with study participation). 
Development of methods to more precisely quantify this indirect selection effect is an area 
for future research.
The idea that participation in a research study can result in beneficial behavioral changes in 
high risk individuals, above and beyond any intervention provided, is pervasive. The 
analyses presented here do not totally discount this possibility, but they do show that the 
benefits of study participation may be substantially less than a naïve analysis that ignores 
RTM would suggest. To fully understand the relative contribution of study participation 
versus RTM among individuals selected for study participation on the basis of high risk 
behaviors, it is important to measure the prevalence of the behaviors of interest in the 
unselected population and to account for regression effects. Declines in high risk behaviors 
beyond those predicted by RTM may be attributable to study participation or other factors.
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Appendix
In HPTN 064 women were evaluated at baseline, 6 and 12 months (i = 0, 1, 2, respectively). 
Let Xi = value of the variable or behavior of interest at visit i, i = 0,1,2. We assume that 
values of X0 are available for all women - for women who are not eligible by the 
unprotected sex criterion, or do not enroll, this information comes from the response to the 
screening questionnaire. The typical enrolled participant has values X0, X1, X2. We write 
the joint distribution as
(A1)
and assume the following model
where Ei is 1 if the woman was participating in the study during the 6 months preceding visit 
i, and 0 otherwise. If X1 or X2 is missing, then the joint distribution for that participant is 
obtained by summing (A1) over the missing value.
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Assuming that the underlying prevalence of the behavior in the unselected population is in 
steady state, we can show that
Proof: Note that P(X0 = 1) = E(X0). Assuming that the behavior is in steady state in the 
unselected population, E(X0) = E(X-i) = p. Then
In practice, the fitted values of the α will be such that Pall is simply equal to the prevalence 
of the behavior in the unselected population.
More importantly, the predicted long-term, steady state prevalence in the unselected 
population after exposure to the study is
Proof: Assuming that the behavior is in steady state after exposure to the study, E(Xi) = 
E(Xi-1) = p. Then
The difference between Ponstudy and Pall represents the study effect.
Let
p0 = Pr(X0 = 1)
pi(r)=Pr(Xi= 1|Xi-1 = r)
nx0(x) = Count of number of observations at time 0 with X0=x among all individuals
nxi(x | r) = Count of number of observations at time i with Xi=x and Xi-1=r, i = 1,2
We use maximum likelihood to estimate α0, α1 and α2. The log-likelihood is
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and standard methods may be used to obtain parameter estimates and standard errors. The 
delta method may be used to compute standard errors for derived quantities such as Pall and 
Ponstudy.
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Figure 1. Study Flow Chart: Screening and Eligibility
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Table 2
Estimated model parameters and derived probabilities/proportions for the outcome, unprotected sex with a 
male in the past 6 months. Percent change due to study participation is computed from equation (2) in the 
manuscript.
Estimate (95% confidence interval)
Parameter estimates α0 -0.186 (-0.34,-0.11)
α1 1.91 (1.68,2.03)
α2 -0.036 (-0.14,0.019)
Observed prevalence at baseline 0.96 (0.95, 0.97)
Estimated pre-study probability1 0.75 (0.74,0.76)
Estimated on-study probability2 0.74 (0.71,0.77)
% of change from baseline due to study 4.4% (-10%, 17%)
1
estimated as  (see appendix)
2
estimated as  (see appendix)
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